Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

IL-32 Antibody (373821), mFluor Violet 450 SE, Novus Biologicals™
SDP

Catalog No. NB348560 Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
0.1 mL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NB348560 0.1 mL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NB348560 Supplier Novus Biologicals Supplier No. FAB30402MFV450
Only null left
Add to Cart
Add to Cart

Rat Monoclonal Antibody

IL-32 Monoclonal antibody specifically detects IL-32 in Human samples. It is validated for Flow Cytometry, CyTOF

Specifications

Antigen IL-32
Applications Flow Cytometry, CyTOF
Classification Monoclonal
Clone 373821
Conjugate mFluor Violet 450 SE
Dilution Intracellular Staining by Flow Cytometry, CyTOF-ready
Formulation 50mM Sodium Borate
Gene Alias IL-32, IL-32alpha, IL-32beta, interleukin 32, interleukin-32, interleukin-32 theta, natural killer cell transcript 4, Natural killer cells protein 4, NK4IL-32delta, TAIFa, TAIFb, TAIFc, TAIFd, TAIFIL-32gamma, Tumor necrosis factor alpha-inducing factor
Host Species Rat
Immunogen E. coli-derived recombinant human IL-32 alpha, Met1-Asn131, Accession # P24001
Quantity 0.1 mL
Regulatory Status RUO
Research Discipline Cancer, Signal Transduction
Primary or Secondary Primary
Gene ID (Entrez) 9235
Target Species Human
Content And Storage Store at 4C in the dark.
Isotype IgG2a
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.